9th Circ. Backs Rare FCA Theory In Huge Drug Prices Program
By Jeff Overley · March 17, 2026, 9:26 PM EDT
In a novel and potentially far-reaching decision, the Ninth Circuit on Tuesday revived a major hospital chain's False Claims Act suit accusing large pharmaceutical companies of massive overcharges in a prominent...
To view the full article, register now.